Pharmazz Inc is a biopharmaceutical company, developing two leading drug candidates, Sovateltide for treatment of acute cerebral ischemic stroke and Centhaquine for treatment of hypovolemic shock. Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/sun-pharma-boosts-investment-in-pharmazz-inc-to-25-million-expands-stake-to-227/121372261